Published: 2021-10-28

Evaluating effects of allo-vedic preparation Raj Nirwan Bati on symptomatic cases of COVID-19 at a tertiary level health care facility in rural setting of northern India

Raj Kumar, Ramakant Yadav, Ramakant Rawat, Naresh P. Singh, Indra K. Sharma, Prashant Yadav


Background: The present pandemic of COVID-19 has created a huge pressure on the current health system of the world as the burden is increasing exponentially day by day. Study evaluated the effect of the novel allo-vedic formulation named Raj Nirwan Bati (RNB) on the clinical symptoms, microbiological, bio-chemical, haematological and radiological profile of patients of COVID-19.

Methods: Prospective single arm, non- randomized clinical trial was conducted which enrolled 40 reverse transcriptase-polymerase chain reaction (RT-PCR) confirmed patients of severe acute respiratory syndrome corona virus-2 (SARS-CoV-2). Each patient was given one dosage of RNB twice a day for 10 days. Patients were evaluated on the clinical symptoms, microbiological, bio-chemical, haematological and radiological profile of patients of COVID-19. Cochran’s Q tests was used to assess statistical significance.

Results: The study revealed that 31 (77.5%) of the COVID-19 cases were having mild, 6 (15%) moderate and 3 (7.5%) having severe form of illness. The association between absence of clinical symptom (fever, cough, breathlessness, sore throat, fatigue and myalgia) and the day of evaluation (first, fifth and tenth day) after start of RNB intervention was found to be statistically significant (p<0.001, p<0.001, p=0.002, p<0.001, p<0.001 and p<0.001) respectively. Thirty (75.0%) of the cases on RNB intervention became negative for SARS-CoV-2 after day 5 on naso-pharyngeal and oro-pharyngeal RT-PCR testing (p<0.001). Statistically significant association was observed only for changes in proportion of cases with elevated lactate dehydrogenase (LDH) values and C-reactive protein (CRP) positive from day 1 to day 10 of RNB intervention (p<0.001).

Conclusions: RNB may be considered a drug to fight against COVID-19.


COVID-19, Ayurvedic medicine, SARS-CoV-2, RT-PCR

Full Text:



Girija PLT, Sivan N. Ayurvedic treatment of COVID-19/SARS-CoV-2: A case report. J Ayurveda Integr Med. 2020;975-9476(20):30042-5.

Shanghai Institute of Materia Medica website, Chinese. Academy of Sciences. A joint research team between the Shanghai Institute of Materia Medica and the University of Science and Technology of the Chinese Academy of Sciences has discovered a group of old and traditional Chinese medicines that may have a therapeutic effect on new pneumonia. Available at: /202001/t20200125_5494417.html. Accessed on 27 May 2020.

Kumar Y, Singh H. In Silico identification and docking-based drug repurposing against the main protease of SARS-CoV-2, causative agent of COVID-19. 2020;13(9):1210-23.

Central Council for Research in Ayurveda and Siddha, 2009, Management of Chikungunya Through Ayurveda And Siddha. New Delhi. Available at: 20report.pdf. Accessed on 27 May 2020.

Kumar R, Yadav R, Rawat R, Bajpai PK, Sharma IK, Kumar S, et al. Raj Nirvan Bati (A Novel Ayurvedic Preparation) in RT-PCR positive COVID-19 Cases: An Interventional Study. Int J Med Sci Curr Res. 2020;3(3):430-40.

Qifang B, Yongsheng W, Shujiang M, Chenfei Y, Xuan Z, Zhen Z, et al. Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study. Lancet Infect Dis. 2020;20(8):911-9.

Yamamoto K, Hasobe M, Saneyoshi M. Inhibitory effect of sulphur-containing purine nucleoside analogues on replication of RNA viruses: selective antiviral activity against influenza viruses. Acta Virol. 1988;32(5):386‐92.

David L, Moldovan B, Vulcu A, Olenic L, Perde-Schrepler M, Fischer-Fodor E, et al. Green synthesis, characterization and anti-inflammatory activity of silver nanoparticles using European black elderberry fruits extract. Colloids Surf B Biointerfaces. 2014;122:767-77.

Jayabharathi M, Musthafa M. Analgesic and anti-inflammatory efficacy on siddha drug rasa chendooram. Semantic Scholar. 2014;74036416.

Ilbäck NG, Wesslén L, Fohlman J, Friman G. Effects of methyl mercury on cytokines, inflammation and virus clearance in a common infection (Coxsackie B3 myocarditis). Toxicol Lett. 1996;89(1):19-28.

Boskabady M, Rakhshandah H, Moetamedshariati V. Bronchodilatory and anticholinergic effects of Carum copticum on isolated guinea pig tracheal chains. Med J Islam Repub Iran. 1998;11(4):329-34.

Boskabady MH, Shaikhi J. Inhibitory effect of Carum copticum on histamine (H1) receptors of isolated guinea-pig tracheal chains. J Ethnopharmacol. 2000;69(3):217-27.

Tousi MAM. Stimulatory Effect of Caruim Coptlcum on Beta-2 adrenoceptors of isolated guinea pig tracheal chains. Med J Islam Repub Iran. 2000;13(4):273-8.

Spices for Lung Diseases. The national medical journal of India. Available at: http://archive. ls-2.pdf. Accessed on 29 May 2020.

Basic elements in a system of chronic health care, Comparison of British, Canadian, Australian and American methodology - 2nd edition. Washington: U.S. Government Printing Office. 1966;316.

Wilkerson RG, Adler JD, Shah NG, Brown R. Silent hypoxia: A harbinger of clinical deterioration in patients with COVID-19. Am J Emerg Med. 2020;159011-3.

Zhou LF, Zhu Y, Cui XF, Xie WP, Hu AH, Yin KS. Arsenic trioxide, a potent inhibitor of NF-κB, abrogates allergen-induced airway hyperresponsive-ness and inflammation. Respir Res. 2006;7(1).

Lippi G, Mattiuzzi C. Hemoglobin value may be decreased in patients with severe coronavirus disease 2019. Hematol Transfus Cell Ther. 2020;42(2):116-7.

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. The Lancet. 2020;395(10223):507-13.

Kumar R, Yadav R, Rawat R, Bajpai PK, Sharma IK, Kumar S, et al. Role of Raj Nirvan Bati in treatment of COVID-19 RT-PCR Positive Cases. Int J Sci Res Methodol. 2020;15(4):1-9.

Abou-Ismaila MY, Diamond A, Kapoor S, Arafah Y, Nayak L. The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management. Thrombosis Research. 2020;194:101-15.

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020;395(10223):497-506.

Xu XW, Wu XX, Jiang XG, Xu KJ, Ying LJ, Ma CL, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ. 2020;368.

Liu Y, Yang Y, Zhang C, Huang F, Wang F, Yuan J, et al. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci. 2020;63(3):364-74.

Feng X, Li S, Sun Q, Zhu J, Chen B, Xiong M, Cao G. Immune-Inflammatory Parameters in COVID-19 Cases: A Systematic Review and Meta-Analysis. Front Med. 2020;7:301.

Lake MA. What we know so far: COVID-19 current clinical knowledge and research. Clin Med. 2020;20(2):124-7.

Eleanor MR, Nightingale ES, Jafari Y, Waterlow NR, Samuel C, et al. COVID-19 length of hospital stay: A systematic review and data synthesis. BMC Med. 2020;18:270.

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. The Lancet. 2020;395:1054-62.

Xiang D, Chen Q, Pang L, Zheng C. Inhibitory effects of silver nanoparticles on H1N1 influenza A virus in vitro. J Virol Methods. 2011;178(1-2):137-42.

Motamed MP, Tabatabaeian N, Sid MT. In vitro antiviral effect of “Nanosilver” on influenza virus. DARU J Pharm Sci. 2009;17(2).

te Velthuis AJW, van denWorm SHE, Sims AC, Baric RS, Snijder EJ, van Hemert MJ. Zn2+ inhibits coronavirus and arterivirus RNA Polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture. PLoS Pathog. 2020;6(11):e1001176.

Chen L, Liu HG, Liu W, Liu J, Liu K, Shang J, et al. Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia. Zhonghua Jie He He Hu Xi Za Zhi. 2020;43(0):e005.

Shi J, Li Y, Zhou X, Zhang Q, Ye X, Wu Z. Lactate dehydrogenase and susceptibility to deterioration of mild COVID-19 patients: A multicenter nested case-control study. BMC Med. 2020;18:168.

Zhou LF, Zhu Y, Cui XF, Xie WP, Hu AH, Yin KS. Arsenic trioxide, a potent inhibitor of NF-κB, abrogates allergen-induced airway hyperresponsive-ness and inflammation. Respir Res. 2006;7(1).

Chen W, Zheng KI, Liu S, Yan Z, Xu C, Qiao Z. Plasma CRP level is positively associated with the severity of COVID‑19. Ann Clin Microbiol Antimicrob. 2020;19.

Rodrigues JC, Hare SS, Edey A, Devaraj A, Jacob J, Johnstone A, et al. An update on COVID-19 for the radiologist-A British society of thoracic imaging statement. Clin Radiol. 2020;75(5):323-5.

Salehi S, Abedi A, Balakrishnan S, Gholamrezanezhad A. Coronavirus Disease 2019 (COVID-19): A Systematic Review of Imaging Findings in 919 Patients. Am J Roentgenol. 2020;1-7.

Barrager E, Veltmann J, Schauss A, Schiller R. A multicentered, open-label trial on the safety and efficacy of methylsulfonylmethane in the treatment of seasonal allergic rhinitis. J Alternat Complement Med. 2002;8(2):167-73.